Nomura Asset Management CO LTD Alkermes Plc. Transaction History

Nomura Asset Management CO LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$23.37 - $28.68 $0 - $0	0 New	0 $0
Q3 2023 Nov 03, 2023	BUY	$27.17 - $31.97 $0 - $0	0 New	0 $0
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $0 - $0	0 New	0 $0
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.29 - $21.74 $441,016 - $554,522	-25,507 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$21.47 - $37.33 $11,722 - $20,382	546 Added 2.19%	25,507 $575,000
Q1 2019 May 10, 2019	BUY	$28.4 - $36.49 $81,309 - $104,470	2,863 Added 12.96%	24,961 $911,000
Q3 2018 Nov 07, 2018	BUY	$38.6 - $46.12 $110,897 - $132,502	2,873 Added 14.94%	22,098 $938,000
Q2 2018 Aug 03, 2018	BUY	$40.56 - $51.36 $5,272 - $6,676	130 Added 0.68%	19,225 $791,000
Q1 2018 May 14, 2018	BUY	$53.61 - $67.26 $2,948 - $3,699	55 Added 0.29%	19,095 $1.11 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $104,918 - $121,858	2,200 Added 13.06%	19,040 $1.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,840	16,840 $976,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.